Follicular Lymphoma, Grade 3b

Also known as: Follicular Lymphoma Grade 3B / Lymphoma, Follicular, Grade 3b / Follicular Grade 3B Lymphoma / Grade 3b Follicular Lymphoma / Grade IIIB Follicular Lymphoma / Follicular Lymphoma Grade IIIb / Follicular lymphoma grade 3b (morphologic abnormality) / Follicular lymphoma grade 3b (disorder)

DrugDrug NameDrug Description
DB16582Lisocabtagene maraleucelA CAR T-cell therapy for treatment resistant or more severe B-cell lymphomas.
DrugDrug NamePhaseStatusCount
DB00958Carboplatin1Terminated1
DB12483Copanlisib1Terminated1
DB14681Cortisone1Completed1
DB00531Cyclophosphamide1Active Not Recruiting1
DB00531Cyclophosphamide1Completed1
DB00531Cyclophosphamide1Recruiting1
DB01234Dexamethasone1Terminated1
DB00997Doxorubicin1Completed1
DB00099Filgrastim1Terminated1
DB01073Fludarabine1Active Not Recruiting1
DB01073Fludarabine1Recruiting1
DB00441Gemcitabine1Terminated1
DB00959Methylprednisolone1Completed1
DB15434Mosunetuzumab1Recruiting1
DB00019Pegfilgrastim1Terminated1
DB09037Pembrolizumab1Active Not Recruiting1
DB09037Pembrolizumab1Completed1
DB00635Prednisone1Completed1
DB00073Rituximab1Completed1
DB00073Rituximab1Terminated1
DB14546Sulfate ion1Completed1
DB00541Vincristine1Completed1
DB02546Vorinostat1Active Not Recruiting1
DB14776Camrelizumab1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting2
DB00694Daunorubicin1 / 2Recruiting1
DB00997Doxorubicin1 / 2Recruiting2
DB06205Hyaluronidase (human recombinant)1 / 2Recruiting1
DB00480Lenalidomide1 / 2Recruiting1
DB00959Methylprednisolone1 / 2Recruiting1
DB00635Prednisone1 / 2Recruiting2
DB15766Retifanlimab1 / 2Recruiting1
DB00073Rituximab1 / 2Recruiting2
DB14765Rivoceranib1 / 2Recruiting1
DB15044Tafasitamab1 / 2Recruiting1
DB14922Tislelizumab1 / 2Recruiting1
DB15043Toripalimab1 / 2Recruiting1
DB00541Vincristine1 / 2Recruiting2
DB11703Acalabrutinib2Not Yet Recruiting1
DB13915Axicabtagene ciloleucel2Recruiting1
DB00958Carboplatin2Terminated1
DB00531Cyclophosphamide2Not Yet Recruiting2
DB00531Cyclophosphamide2Recruiting1
DB00531Cyclophosphamide2Terminated1
DB11731Depatuxizumab mafodotin2Terminated2
DB00997Doxorubicin2Terminated1
DB00773Etoposide2Terminated1
DB01073Fludarabine2Not Yet Recruiting2
DB01073Fludarabine2Recruiting1
DB01181Ifosfamide2Terminated1
DB00480Lenalidomide2Recruiting1
DB16582Lisocabtagene maraleucel2Not Yet Recruiting1
DB16582Lisocabtagene maraleucel2Recruiting1
DB15434Mosunetuzumab2Recruiting1
DB00075Muromonab2Recruiting1
DB12240Polatuzumab vedotin2Recruiting1
DB00635Prednisone2Terminated1
DB00073Rituximab2Terminated2
DB15044Tafasitamab2Recruiting1
DB12887Tazemetostat2Recruiting1
DB13881Tisagenlecleucel2Recruiting1
DB00541Vincristine2Terminated1
DB15035Zanubrutinib2Recruiting1
DB00928Azacitidine2 / 3Recruiting1
DB14681Cortisone2 / 3Recruiting1
DB00531Cyclophosphamide2 / 3Recruiting1
DB00997Doxorubicin2 / 3Recruiting1
DB00959Methylprednisolone2 / 3Recruiting1
DB00635Prednisone2 / 3Recruiting1
DB00073Rituximab2 / 3Recruiting1
DB14546Sulfate ion2 / 3Recruiting1
DB00541Vincristine2 / 3Recruiting1
DB16672EpcoritamabNot AvailableApproved for Marketing1